| The immune landscape of cancer V Thorsson, DL Gibbs, SD Brown, D Wolf, DS Bortone, THO Yang, ... Immunity 48 (4), 812-830. e14, 2018 | 4999 | 2018 |
| The 2016 WHO classification of tumours of the urinary system and male genital organs—part A: renal, penile, and testicular tumours H Moch, AL Cubilla, PA Humphrey, VE Reuter, TM Ulbright European urology 70 (1), 93-105, 2016 | 4748 | 2016 |
| Integrative genomic profiling of human prostate cancer BS Taylor, N Schultz, H Hieronymus, A Gopalan, Y Xiao, BS Carver, ... Cancer cell 18 (1), 11-22, 2010 | 4184 | 2010 |
| Integrative clinical genomics of advanced prostate cancer D Robinson, EM Van Allen, YM Wu, N Schultz, RJ Lonigro, JM Mosquera, ... Cell 161 (5), 1215-1228, 2015 | 3970 | 2015 |
| An integrated TCGA pan-cancer clinical data resource to drive high-quality survival outcome analytics J Liu, T Lichtenberg, KA Hoadley, LM Poisson, AJ Lazar, AD Cherniack, ... Cell 173 (2), 400-416. e11, 2018 | 3067 | 2018 |
| Oncogenic signaling pathways in the cancer genome atlas F Sanchez-Vega, M Mina, J Armenia, WK Chatila, A Luna, KC La, ... Cell 173 (2), 321-337. e10, 2018 | 2829 | 2018 |
| The molecular taxonomy of primary prostate cancer A Abeshouse, J Ahn, R Akbani, A Ally, S Amin, CD Andry, M Annala, ... Cell 163 (4), 1011-1025, 2015 | 2824 | 2015 |
| Comprehensive molecular characterization of urothelial bladder carcinoma Cancer Genome Atlas Research Network Nature 507 (7492), 315, 2014 | 2780 | 2014 |
| Pan-cancer analysis of whole genomes Nature 578 (7793), 82-93, 2020 | 2513* | 2020 |
| Comprehensive molecular characterization of muscle-invasive bladder cancer AG Robertson, J Kim, H Al-Ahmadie, J Bellmunt, G Guo, AD Cherniack, ... Cell 171 (3), 540-556. e25, 2017 | 2495 | 2017 |
| Comprehensive characterization of cancer driver genes and mutations MH Bailey, C Tokheim, E Porta-Pardo, S Sengupta, D Bertrand, ... Cell 173 (2), 371-385. e18, 2018 | 2426 | 2018 |
| Cell-of-origin patterns dominate the molecular classification of 10,000 tumors from 33 types of cancer KA Hoadley, C Yau, T Hinoue, DM Wolf, AJ Lazar, E Drill, R Shen, ... Cell 173 (2), 291-304. e6, 2018 | 2272 | 2018 |
| Clinical-grade computational pathology using weakly supervised deep learning on whole slide images G Campanella, MG Hanna, L Geneslaw, A Miraflor, ... Nature medicine 25 (8), 1301-1309, 2019 | 2199 | 2019 |
| Machine learning identifies stemness features associated with oncogenic dedifferentiation TM Malta, A Sokolov, AJ Gentles, T Burzykowski, L Poisson, JN Weinstein, ... Cell 173 (2), 338-354. e15, 2018 | 1847 | 2018 |
| The 2016 WHO classification of tumours of the urinary system and male genital organs—part B: prostate and bladder tumours PA Humphrey, H Moch, AL Cubilla, TM Ulbright, VE Reuter European urology 70 (1), 106-119, 2016 | 1782 | 2016 |
| The Heidelberg classification of renal cell tumours G Kovacs, M Akhtar, BJ Beckwith, P Bugert, CS Cooper, B Delahunt, ... The Journal of Pathology: A Journal of the Pathological Society of Great …, 1997 | 1705 | 1997 |
| International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee JI Epstein, MB Amin, VR Reuter, FK Mostofi, World Health Organization Am J Surg Pathol 22 (12), 1435-1448, 1998 | 1703 | 1998 |
| A contemporary prostate cancer grading system: a validated alternative to the Gleason score JI Epstein, MJ Zelefsky, DD Sjoberg, JB Nelson, L Egevad, ... European urology 69 (3), 428-435, 2016 | 1696 | 2016 |
| Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer MJ Zelefsky, SA Leibel, PB Gaudin, GJ Kutcher, NE Fleshner, ... International Journal of Radiation Oncology* Biology* Physics 41 (3), 491-500, 1998 | 1221 | 1998 |
| Genomic correlates of clinical outcome in advanced prostate cancer W Abida, J Cyrta, G Heller, D Prandi, J Armenia, I Coleman, M Cieslik, ... Proceedings of the National Academy of Sciences 116 (23), 11428-11436, 2019 | 1211 | 2019 |